Home/Filings/4/0001104659-18-041871
4//SEC Filing

Sard Mark 4

Accession 0001104659-18-041871

CIK 0001264587other

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 9:31 PM ET

Size

4.8 KB

Accession

0001104659-18-041871

Insider Transaction Report

Form 4
Period: 2018-06-21
Sard Mark
Director
Transactions
  • Award

    Common Stock

    2018-06-21+20,46836,468 total
Footnotes (2)
  • [F1]The restricted shares will vest according to the following schedule: 6,823 shares on 6/21/2019, 6,823 shares on 6/21/2020 and 6,822 shares on 6/21/2021.
  • [F2]Of the 36,468 shares, 20,468 shares are restricted stock.

Documents

1 file

Issuer

STEMLINE THERAPEUTICS INC

CIK 0001264587

Entity typeother

Related Parties

1
  • filerCIK 0001737651

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 9:31 PM ET
Size
4.8 KB